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This publication focuses on processes which disrupt proper 
development of the hip. Four pathomechanisms underlying human 
developmental defects are described in literature, i.e. dysplasia, 
malformation, disruption, and deformity. In the case of hip 
development, arguably the greatest challenge involves confusion 
between dysplasia and deformity, which often leads to misdiagnosis, 
incorrect nomenclature, and incorrectly chosen treatment. 
The paper presents a description of hip joint development disorders in 
the context of their pathomechanisms. An attempt was made to 
answer the question whether these disorders are rooted in a primary 
disorder of tissue growth, resulting in its incorrect anatomy, or are the 
result of anatomical deformation with secondary modifications in 
tissue structures of a degenerative or adaptive nature, based on 
Deplesch-Heuter-Volkmann growth and remodeling laws. In addition, 
emphasis is placed on attention to the presence of the so-called 
clinically and diagnostically mute cases. The need to augment 
diagnostic procedures with genetic tests in order to increase the 
sensitivity of screening has also been suggested. Based on the 
arguments presented in the paper, a new division of developmental 
hip disorders has been proposed.
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Introduction
Many studies of hip development disorders have been 
performed1, leading to a number of proposed diagnostic and 
treatment options2. Despite the impressive collection of studies 
documented in scientific publications, the etiology of devel-
opmental disorders of the hip joint still cannot be formu-
lated with clarity1,3–5. Even so, the etiology of these diseases 
is known to be multifactorial, combining genetic factors (with 
varying intensity and expression periods) and environmental 
factors affecting the fetal and postnatal periods6,7. Normal 
hip growth and development depend on a genetically deter-
mined balance between the growth of the acetabular and trira-
diate cartilages and a properly located and centered femoral 
head6,8,9.
Experimental studies have revealed that the development of 
the acetabulum depends on a coded geometric pattern10,11. The 
concave shape of the acetabulum results from the presence 
of a round femoral head inside. In addition, many other fac-
tors affect the acetabular depth, including growth within the 
acetabular cartilage, growth through apposition under the 
perichondrium layer, and growth of adjacent bones (iliac, sciatic 
and pubic)8,9.
The incidence of developmental hip growth disorders varies 
by population. It is close to 0% among newborns in China and 
Africa, but rises to 1% in Caucasian newborns, with the inci-
dence of hip dislocations at approximately 0.1%12. Notably, 
these differences may result from environmental factors, such 
as the manner of childcare, rather than genetic issues. A positive 
family history of hip development disorders is found in 12–33% 
of patients and is more often observed in female children 
(80% of cases)12.
As described in literature, three independent but equivalent 
pathomechanisms underlying hip joint development disorders, 
i.e. malformation, dysplasia, and deformity, can be identified4. 
The fourth pathomechanism of developmental disorders – dis-
ruption – has been excluded from further considerations because 
its relevance to developmental hip disorders remains unproven. 
With the exception of deformity, which falls within the group 
the of so-called “packaging problems”, the three remaining 
pathomechanisms are collectively referred to as “production 
problems”12.
Many recent scientific reports do not take into account the dif-
ferences between the above-mentioned pathomechanisms. 
An equality sign is placed between them, treating them as 
synonyms usually grouped under one name, i.e. developmen-
tal dysplasia of the hip (DDH)13–15. Some publications use the 
following terms interchangeably: congenital hip dysplasia3, con-
genital hip dislocation16, developmental deformity of the hip17. 
Others contain statements such as “… malformation of anatomical 
structures occurs in dysplasia, which at the time of embryonic 
development were still normal ...” or “…developmental 
hip dysplasia is more deformity than malformation ...”12. 
According to the International Classification of Diseases 
and Health Problems (Q65 to Q79), the term “congenital hip 
dislocation” remains valid18.
To precisely explain the need to distinguish and organize 
these issues, we present and explain the following definitions, 
based on which a new division of hip developmental disorders 
is proposed.
A congenital defect is a disorder present since birth. It is a 
general term, broadly describing the structural, behavioral, 
functional and metabolic damage that occurred in prenatal life, 
and which is diagnosed after birth or later in life19.
Malformation (Latin: malformatio) is a term frequently 
used by English-speaking authors to refer to developmental 
disorders in general. More specifically, however, malformation 
represents just one of the four pathomechanisms of developmental 
disorders4. Malformation concerns developmental disorders, 
but only during the embryonic period. Referring to develop-
mental changes which occur after this period as “malformation” 
is incorrect.
Malformation of the mesenchymal primordium of the hip joint 
is a type of birth defect caused by a primary disorder of hip 
development during the embryonic period, during differen-
tiation or organogenesis. The primary disorder affects cell 
proliferation, differentiation, migration, apoptosis or cell inter-
communication processes. Primary impairment of cell function 
inhibits, delays or directs tissue development in the wrong direc-
tion, causing improper formation of anatomical structures of 
the hip4. Malformation underlies the development of congenital 
teratogenic hip dislocation.
Dysplasia of the hip is a type of disorder in which abnormally 
developing tissue (often excessively flaccid) results in faulty 
hip anatomy and evolves over time. Anatomical structures of t 
he hip, normal during embryonic development, gradually 
become abnormal for various reasons10,20. Dysplasia may be 
environmentally or genetically conditioned. Dysplastic changes, 
along with malformation and disruption, may be collectively 
referred to as “production problems”. Hip dysplasia can occur 
both in the prenatal (early dysplasia) and postnatal (late dysplasia) 
period21. These disorders do not tend to self-heal12.
Deformiy of the hip joint is an example of a developmental 
disorder in which properly developed structures are deformed 
during growth, as a result of mechanical factors. This can 
occur both in the pre- and postnatal periods. If the mechani-
cal factor is active in the prenatal period, then we may refer to 
it as a “packaging problem”, associated with intrauterine fetal 
modeling. Disorders of this type are unlikely to cause growth 
disorders – rather, they tend to disappear with age and self-heal12.
A developmental disorder is disorganization in the anatomi-
cal structure of the osteoarticular system that appears after 
some time, is absent or invisible at birth and has a tendency to 
either self-heal or worsen over time. In English literature, the 
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term “structural defect” is often used in the context of devel-
opmental disorders to emphasize the anatomical nature of the 
defect.
When referring to dysplasia and deformity, it is reasonable 
to introduce an additional term – “developmental disorder” 
– because we are talking about anomalies with a tendency to 
self-heal or become more severe over time4. Developmental 
dysplasia or developmental deformity of the hip, depending 
on the time of occurrence, can be early (primary – invisible and 
present at birth) or late (secondary – absent, and appearing 
after some time)12.
As disruption has not been described in the context of devel-
opmental hip joint disorders, and malformation is relatively 
easily diagnosed as a component of congenital anomalies, the 
main focus is on the distinction between dysplasia and 
deformity.
The aforementioned distinction is extremely important because 
it projects the course of treatment and prognosis of hip joint 
development disorders. It influences the choice of various 
conservative or surgical treatment strategies aimed at main-
taining or restoring the normal growth potential of anatomical 
structures12. Misdiagnosis can lead to incorrect therapeutic 
management and, consequently, to deepening disability, thus 
significantly increasing the cost of treatment22,23.
The following is a discussion of the pathogenesis of devel-
opmental hip disorders with a focus on dysplasia and 
deformities.
Discussion
Malformation as a disorder of the hip joint formation 
process
The pathomechanism of malformation cannot be the root cause 
of developmental hip disorder leading to dysplasia because 
it is only in the seventh week of life within the mesenchyme 
that the hip joint develops a fissure secreting the future 
femoral head and the acetabulum. Therefore, the first period 
when hip dislocation, and thus developmental hip dysplasia, 
may occur is the eleventh week of fetal life – the time when the 
hip joint is fully formed6. In the case of malformation, the most 
frequent causative factor is congenital anomalies syndrome, 
which generally does not pose major diagnostic difficulties. 
The effects of such congenital changes are present and visible 
immediately after childbirth24.
Dysplasia and deformity as developmental disorders of 
the hip joint
In the literature, dysplasia is considered in two aspects: 
dysplasia as a precancerous lesion (applies only to epithelial 
tissue, which is outside of the scope of this discussion), and 
dysplasia as a developmental disorder, involving incorrect 
organization or function of cells in a specific tissue (described 
as “production problems”), which is under consideration12. 
Dysplasia, which is a developmental disorder of the hip, can 
be grouped under the so-called osteoarticular dysplasia 
epiphyseal type20,25. It is characterized by abnormal growth 
potential of tissue structures underlying anatomical and 
functional changes in the growing hip8,9. In such cases, using 
the term dysplasia is fully justified.
Risk factors for developmental dysplasia can include envi-
ronmental or genetic conditions on both the mother and child 
side. Many scientific reports contain information on the impact 
of elevated level of biochemical factors on the occurrence 
of developmental dysplasia, e.g. female hormones (e.g. 
relaxin, estrogens) and biochemical markers of nutritional sta-
tus (e.g. calcium, vitamins C and D)1. Regarding the relation-
ship between the concentration of the hormone relaxin derived 
from the mother in the blood of the fetus and instability of 
hip joints, it was established that facts contradict the ear-
lier assumption that hip instability coincides with increased 
relaxin concentrations in newborns. Instead, results indicate that 
hip instability frequently accompanies decreasing relaxin lev-
els. The authors therefore assumed poorer mobilization of the 
pelvis and the birth canal during pregnancy as a result of the 
lower concentration of relaxin, which may result in greater 
pressure on the fetus in the perinatal phase26. Abnormalities 
caused by the disturbed balance of biochemical factors on the 
part of the mother can be expressed in the immaturity of the 
tissues of the child’s hip joint and the delay of their develop-
ment in the prenatal period26–28. Such changes may be temporary 
and transient. With the right positioning of the hips, proper 
care of the newborn and then the baby, in most cases, the cor-
rect architecture of the anatomical elements of the hip can be 
restored7.
Other studies report genetic disorders of the fetus underlying 
dysplastic changes in the hip joints. It has been confirmed that 
relaxation of ligaments and joint capsules, as well as irregulari-
ties in collagen metabolism, are associated with developmental 
dysplasia.
It has also been shown that some types of HLA A, B, and D, as 
well as mutations in specific genes or regulatory sequences, 
including genetic changes on chromosome 17 (17q21), predis-
pose the child to developmental hip disorders of a dysplastic 
nature5,29,30. This group likely covers cases of developmen-
tal disorders characterized by prevalence of residual, recurrent 
and late forms that are resistant to treatment.
In situations (as assumed by the Delpesch law) where a cor-
rectly growing hip joint is affected by an external mechanical 
force, whether intracorporal (e.g. extra-articular contracture) 
or extracorporeal (e.g. incorrect position of the lower limb), 
leading to deformation of its anatomical structure, we are 
dealing with deformity12. Prolonged action of such factors, 
combined with ongoing growth, may result in ultimate 
subluxation or even full dislocation. In such cases, the term 
“deformity” is fully justified.
In deformity, change in the shape of the growing hip joint due 
to external extra-articular forces is not accompanied by dis-
ruption of the structure and tissue function in the initial phase, 
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as is the case with dysplasia. Uneven distribution of forces act-
ing on the roof of the growing acetabulum by the moving 
head leads to inhibition of growth of cartilage and bone 
tissue, their sclerosis and ultimately steep positioning of the 
acetabulum roof10. Atrophy of the acetabulum roof is accom-
panied by excessive bone growth within its fossa, i.e. in the 
unloaded zone. As a result of the loss of modeling and sliding out 
of the femoral head during acetabulum growth, the acetabulum 
bottom becomes bold, the acetabulum roof flattens and the 
acetabulum becomes shallow.
These processes of growth and remodeling of cartilage and 
bone tissue are of a secondary character and comply with 
Wolff-Delpesch laws, later developed by Hueter-Volkmann, 
Pauwels, and Arndt-Schmidt12.
The Hueter-Volkmann law also explains the presence of the 
most frequently observed pathological change in early post-
natal hip dislocation, which is neolimbus (Ortolani positive 
symptom)6,12. The lack of physiological interaction (mutual 
pressure) between the head and the posterior edge of the 
acetabulum leads to excessive hypertrophy of the hyaline 
cartilage (neolimbus) in the upper, posterior and lower periphery 
of the acetabulum with the labrum curved out (pulled by a joint 
capsule in the dislocated hip)12.
Deformity caused by mechanical factors, which is usually 
the result of intrauterine modeling, especially in the last tri-
mester of pregnancy (hence the term “packaging problems”) 
usually does not cause disturbances in the growth poten-
tial of joint tissues, as observed in dysplasia or malformation. 
Instead, it exhibits a tendency to self-heal and rarely leads to 
relapse12.
This group includes cases of fetuses with abnormal breech posi-
tion and ultra-position of limbs which self-heal or recover 
in the postnatal period, assisted by short-term conservative 
therapy7. Treatment involving restoration of the compact 
joint with concentric maintenance of the head in the acetabu-
lum ensures optimal development conditions. If reposition is 
effectively maintained, the acetabulum, femoral head and femoral 
neck in anterversion undergo remodeling as a result of their 
normal growth potential. Restoration of the correct and stable 
joint connection between the femoral head and the acetabulum 
can lead to remodeling of the deformity and normalization 
of the morphology of the hip (due to developmental 
plasticity)12. The potential and growth time of the hip joint 
are closely related and depend on genetic and environmental 
factors12. These include genetic variations, e.g. of the SNP 
type, modulating the activity of proteins important from the 
point of view of tissue function, along with factors such as 
nutrition, general health, hormone concentration, mechanical 
forces and physiological age30. Therefore, during diagnostics and 
treatment, dysplastic and deformative cases should be considered 
together.
Time can be an ally or an enemy, depending on whether 
growth potential remains normal. If it does, as in the case 
of deformity, then growth may promote development of 
correct anatomical structures (after correction and concentric 
arrangement of the elements of the hip joint). In the absence 
of normal growth potential, as with dysplasia, deformity of 
anatomical structures may deepen12 as growth progresses, even 
if a concentric position of the hip is achieved (recurrent, residual 
dysplasia resistant to treatment).
Clinically and diagnostically mute hip developmental 
disorders
It is nearly impossible to distinguish between dysplasia and 
hip joint deformity on the basis of physical examination and 
imaging, e.g. ultrasound, X-ray and MRI. The procedures 
used in many countries, which call for imaging when Ortolani, 
Barlow and limited abduction tests are positive, may not be 
sufficient12,15. Because of the difficulty in correctly distin-
guishing between these two pathomechanisms, misdiagnosis 
often follows, and terminology is incorrectly applied. In the 
diagnosis and treatment of developmental hip joint disorders, 
there is a notable lack of uniform diagnostic and therapeutic 
standards in various countries around the world. This applies to 
the frequency of examinations and their complementarity15,31–34. 
There is also the danger of not detecting so-called clini-
cally mute developmental disorders6,35. These are cases in 
which physical examination does not provide information 
about pathological changes at the joint level, which, however, 
become evident under imaging15. Literature describes cases 
of otherwise healthy children with normal physical examina-
tions and radiographs of the hip in the first 3 months of life, 
who later developed hip dislocations21.
The opposite situation – involving diagnostically mute devel-
opmental disorders – may also occur. This condition occurs 
when physical examination clearly indicates a developmental 
disorder of the hip joint, and even its total displacement, while 
additional imaging tests do not confirm such abnormalities21. 
The joint can be anatomically normal but functionally abnor-
mal, e.g. due to limitation of hip abduction. Passivity towards 
asymmetrical movement of the hip abduction can lead to a 
developmental hip disorder which often results in dislocation15. 
In this context, it should be noted that in cases of develop-
mental hip disorder dysplasia and deformity, physical exami-
nation remains the priority, but it must be supplemented with 
imaging tests. Complementarity of physical examinations 
and imaging tests may reduce the number of undetected 
diagnostically and clinically silent cases.
Early detection of cases of late dysplasia
In many cases of dysplasia in the first weeks of the child’s life, 
the doctor will not observe pathological anatomical changes 
of the hip and will not detect tissue changes despite the fact 
that they are present. These changes may lead to joint discon-
gruity, deepening during hip development, as observed in late 
forms of dysplasia.
In the case of late dysplasia, diagnoses are most often 
made in a situation when there are degenerative changes in 
the hip joint presenting with pain in the 3rd or 4th decade 
of life6.
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Treatment implemented at this stage is symptomatic and 
clearly less effective than it might have been had the problem 
been noticed earlier. In order to avoid such situations, the 
possibility of implementing additional diagnostic tests should 
be considered. Given the development of high-throughput 
methods and the corresponding decrease in their cost, it is 
worth considering the implementation of a genetic test-
ing procedure for detecting genetic variations responsible for 
pathological phenotypes. Knowledge about the genotype of 
patients with dysplastic changes would facilitate therapeutic 
planning in early cases of dysplasia, particularly with regard 
to abnormalities which are not phenotypically revealed until 
a later period in the patient’s life15. Such variations may explain 
the presence of short- and long-term tissue function distur-
bances, which lead to anatomical disorders of acetabulum 
development along with functional disorders of extra-articular 
tissues (contracture, excessive flaccidity)6,36,37.
Several papers have been published on the topic of the genetic 
background of hip dysplasia; however, these studies always 
focus on changes occurring in specific genes. A study of the 
full range of genomic sequences with all potential variations 
(NGS sequencing studies) would allow us to describe the entire 
spectrum of variations comprising of the observed dysplastic 
changes29,30. Identification of e.g. single nucleotide changes 
(correlated with pathological phenotypes and affecting regu-
latory sequences which modulate protein functions) could 
significantly increase the level of diagnostic accuracy38,39.
Considering the above facts, it should be noted that nowadays 
there may still be clinically and diagnostically mute cases in 
neonatal hip tests, since genetic diagnostics are not yet routine. 
Integration of genetic testing with medical procedures would 
enable objective assessment of the situation at an early stage in 
both early and late dysplasia.
Detection of differences at the level of genomic DNA, char-
acteristic of the group of patients with dysplasia, would 
allow classification of this disorder with varying degrees of 
aggressiveness based on the obtained genetic profiles. In the 
future, this could serve as a tool for planning personalized ther-
apy and become part of international standards15,31–34. Incor-
rect diagnosis resulting from incomplete patient data is the main 
cause of disability in childhood and adulthood, and treating 
such disability imposes a serious burden on state budgets40. With 
modern diagnostic tools the consequences of overlooking the 
defects could be largely avoided. In addition, this would sensi-
tize the attending physicians to the possibility of late presenta-
tion of the abnormality, its resistance to treatment and eventual 
recurrence. Vigilance in the treatment process would facilitate 
thoughtful planning of the course of therapeutic manage-
ment and thus improve the quality of life of patients in the 
future41.
Classification of developmental hip disorders
Based on the above considerations, a classification of develop-
mental hip disorders was proposed depending on the etiology 
of the defect.
I. Developmental disorders of the hip joint associated with 
“production problems”
In these abnormalities, the tissues forming the hip joint are 
primarily defective (dysplastic). Primary disturbed tissue 
development results in secondary disturbed hip joint anatomy.
1) Teratogenic congenital hip dislocation
This is an example of a “tissue production” disorder which 
involves malformation at the embryonic stage, i.e. before the 
end of hip joint differentiation. It can be caused by genetic and/
or biochemical and/or biophysical factors in the embryonic 
period.
2) Developmental dysplasia of the hip (DDH)
Another “tissue production” disorder involving dysplasia, 
which may begin to manifest in the prenatal (fetal) period, i.e. 
from the time of hip joint formation (at 11–12 weeks of age) 
throughout the postnatal period. It may be caused by genetic 
and/or environmental factors. 
Depending on the time of onset, DDH can be divided into:
A) Early (primary) developmental dysplasia of the hip
This disorder refers to the fetal phase of the prenatal period 
including the postnatal period up until the end of the 3rd month 
of life.
B) Late (secondary) developmental hip dysplasia
This disorder refers to the postnatal period – after 3 months of 
age.
II. Developmental disorders of the hip associated with 
so-called “packaging problems”
In these disorders, properly formed tissues of the anatomical 
structures of the hip joint are deformed due to prolonged pres-
ence of mechanical factors. An untreated deformity may, in the 
long term, cause secondary hip tissue changes in accordance 
with the remodeling and adaptation laws of Delpesch-Heuter-
Volkmann – this mainly concerns bone tissue (atrophy and scle-
rosis in the overloaded zone, hypertrophy and low-density bone 
structure in the unloaded zone)42.
1) Early (primary) developmental hip deformity
This disorder occurs in the prenatal (fetal) period and the 
postnatal period until the end of the 3rd month of life. Depending 
on the time of exposure to the deforming mechanical 
factor, we can distinguish a number of different risk factors. In 
the fetal period, these include: ultra position of the fetal lower 
limbs; breech position of the fetus; left hip joint – pressure 
on the sacrum prior to and during head delivery; oligohydramnios 
– intrauterine narrowness; primigravida.
Risk factors present in the postnatal period (up until the end 
of the 3rd month of life) include incorrect diapering and 
extra-articular contractures.
2) Late (secondary) developmental deformity of the hip
This disorder occurs in the postnatal period, after the 3rd 
month of life. Risk factors include improper care, neurogenic 
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disorders (e.g. disorders of muscular balance in cerebral palsy, 
myelomeningocele, perinatal neuromuscular dystonia), inflam-
matory conditions (e.g. viral or bacterial hip inflammation), 
extra-articular contractures within e.g. adductor muscles of the 
hip caused by: idiopathic muscle fibrosis, ionizing radiation 
fibrosis, postinflammatory fibrosis (viral muscle damage, bacte-
rial descent processes after abscesses) and fibrosing postpartum 
hematomas.
III. Developmental disorders of the hip associated with the
so-called “packaging problems” and “production problems”
(mixed)
In these disorders we deal with situations in which the
deformity has a secondary effect on tissue quality, or deformity
changes are superimposed upon dysplastic changes.
1. Dysplastic disorder with secondary deformity changes
After birth, the dysplastic hip joint with a disturbed congruence
is affected by an additional iatrogenic mechanical external force,
e.g. associated with incorrect diapers.
2. Deformity or dysplastic disorder with secondary degenera-
tive tissue changes
Prolonged maintenance of untreated deformity or dysplasia and
the resulting lack of joint congruence may result in secondary
degenerative changes. These changes are a direct consequence
of improper nutrition of joint and extra-articular tissues caused
by pathological intra- and extra-articular forces.
Conclusions
Dysplasia, malformation, and deformity are three of the four 
basic pathomechanisms leading to developmental hip disorders 
which are often not disambiguated at the clinical level and are 
therefore incorrectly named. Because malformation is relatively 
readable for the clinician, it is the least difficult to recognize. 
However, it is far more difficult to distinguish between dyspla-
sia and deformity, because existing standards do not provide 
explicit methods along with a full range of diagnostic options. 
Nevertheless, this distinction is crucial and not merely a 
theoretical problem – it may influence medical practice, 
affecting patients’ quality of life and reducing treatment costs.
To achieve this goal, it is necessary to perform a full diagnos-
tic process (physical examinations, imaging tests, genetic tests) 
in the immediate postnatal period to determine whether we’re 
dealing with:
• an anatomically normal hip joint with a normal growth potential
• teratogenic congenital dislocation of the hip with disturbed tis-
sue growth potential in the malformation process (embryonic
period)
• a dysplastic hip joint with disturbed growth potential in
the prenatal period (fetal period) (cases of early dysplasia)
• an initially anatomically normal hip joint, but with a changed
genotype that interferes with the potential for tissue growth
in the postnatal period (cases of late dysplasia)
• a deformed hip joint with normal growth potential occur-
ring in the pre- and postnatal periods (cases of early and late
developmental deformities)
• a dysplastic hip joint with external deforming mechanical
forces affecting it during the fetal or postnatal period
• a deformed or dysplastic hip joint which is affected by inter-
nal or external mechanical forces (joint dyscongruence) resulting
in secondary degenerative tissue changes.
In addition to routine procedures, specialists will likely have 
to rely on additional genetic testing to account for the pos-
sibility of recurrent residual dysplasia refractory to treatment  
despite a properly managed therapeutic process. In addition, 
such tests may help quickly explain the specific type of dys-
plasia and late deformities, preventing premature termination  
of diagnosis and treatment and thereby improving the qual-
ity of life of patients. The presented procedure would reduce 
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In the paper, the Authors discuss a quite controversial idea that developmental dysplasia of the 
hip is not a pure dysplasia, but partly belongs to a group of malformations, partly to deformities 
and partly to developmental disorders. Thus, they proposed their own classification of the DDH 
basing their idea. 
 
Unfortunately, according to DDH, its classification of malformations, deformities or developmental 
disorders is very controversial, as DDH in fact does not fulfill the definitions of those conditions. 
 
According to definitions given by several widely accepted sources, including https://medical-
dictionary.thefreedictionary.com/malformation, 
https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajmg.a.36249 and Wikipedia, malformation is 
associated with a disorder of tissue development that often occurs in the first trimester. 
Deformation is equal to malformation (https://medical-
dictionary.thefreedictionary.com/malformation). 
 
Authors assumed that pathological changes that are observed in the hip joint affected by 
something that is nowadays called DDH could originate from malformation, deformity and 
developmental disorders. In the paragraph: “… Many recent scientific reports do not take into account 
the differences between the above-mentioned pathomechanism. An equality sign is placed between 
them, treating them as synonyms usually grouped under one name, i.e. developmental dysplasia of the 
hip (DDH)13–15. Some publications use the following terms interchangeably: congenital hip dysplasia3, 
congenital hip dislocation16, developmental deformity of the hip17. Others contain statements such as 
“… malformation of anatomical structures occurs in dysplasia, which at the time of embryonic 
development were still normal ...” or “…developmental hip dysplasia is more deformity than 
malformation ...”12. According to the International Classification of Diseases and Health Problems (Q65 
to Q79), the term “congenital hip dislocation” remains valid18…” they use several footnotes that do 
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not confirm their theses. Moreover, literature positions 13, 14 and 15 do not discuss 
malformation, deformation, deformity nor developmental disorders et al. In the position nr 14, the 
words deformity and developmental disorder were used one time only each and in a totally 
different meaning than that presented by Authors of the analyzed publication. 
The statement: “…Malformation of the mesenchymal primordium of the hip joint is a type of birth 
defect caused by a primary disorder of hip development during the embryonic period, during 
differentiation or organogenesis…” do not correspond to its definition, since malformation is 




“…The pathomechanism of malformation cannot be the root cause of developmental hip disorder 
leading to dysplasia because it is only in the seventh week of life within the mesenchyme that the hip 
joint develops a fissure secreting the future femoral head and the acetabulum. Therefore, the first 
period when hip dislocation, and thus developmental hip dysplasia, may occur is the eleventh week of 
fetal life – the time when the hip joint is fully formed6. In the case of malformation, the most frequent 
causative factor is congenital anomalies syndrome, which generally does not pose major diagnostic 
difficulties. The effects of such congenital changes are present and visible immediately after childbirth24
…”. Methinks that it is not especially the fissure of the hip joint that secretes femoral head and 
acetabulum. Both structures are rather formed in consequence of endochondral ossification of 
cartilaginous structures of the three pelvic bones at the ypsilon cartilage and femoral head. 
“…dysplasia as a precancerous lesion…” could hardly be proven. Authors should focus on the subject 
of their paper - that is on hip dysplasia. 
The paragraph “…Early detection of cases of late dysplasia. In many cases of dysplasia in the first 
weeks of life, the doctor will not be able to observe clinically pathological signs and thus will not be able 
to “detect … dysplasia” despite the fact that they are present. These changes may lead to joint 
discongruity, deepening during hip development, as observed in late forms of dysplasia. 
In the case of late dysplasia, diagnoses are most often made in a situation when there are degenerative 
changes in the hip joint presenting with pain in the 3rd or 4th decade of life6…” seems to focus on 
“late” dysplasia. Nevertheless, that’s rather a degenerative joint disease that makes the problem, 
not hip dysplasia itself at the third and fourth decade of life. Authors should define the term “early 
detection … of late dysplasia”. Do they mean the diagnosis? If so - why an “early” diagnosis is 
important in such “antiquated” dysplasia? 
Proposed classification should be discussed in a group of investigators and practitioners, including 
geneticists, neonatologists, pediatricians, orthopedists, etc. Proposed treatment, albeit scanty, as 
well. In classification generally accepted definitions and terms should be abided by. 
Paper requires linguistic improvements and English language edit.
 
Is the topic of the review discussed comprehensively in the context of the current 
literature?
Partly
Are all factual statements correct and adequately supported by citations?
Partly
Is the review written in accessible language?
Yes
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Are the conclusions drawn appropriate in the context of the current research literature?
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We would like to thank the reviewer for his time and the opportunity to develop the topic 
and explain the issues that turned out to be ambiguous and unclear on the reception of our 
study. The posted comments made us aware which threads in our paper should be deeply 
clarified. We will publish an updated version of the manuscript soon. 
In our manuscript, we tried to organize many years of knowledge, documented in 
professional literature, which in some areas is misleading due to juggling by the 
terminology in some medical issues. For this reason, in the title of the manuscript, we have 
included the names of the main pathomechanisms of hip defects, i.e. dysplasia, deformity, 
malformation, which are often used as synonyms but are not. Based on the publication 
references, we have demonstrated the line of our reasoning and the proposed division of 
hip developmental defects derived from it. 
It is difficult for us to argue with the reviewer because the reviewer's comments are 
incorrect in the assumptions themselves, which we will try to justify below. Moreover, the 
conceptual set we use is not consistently used in two-sided argumentation. We understand, 
however, where it comes from, namely from the great mess in the nomenclature in which 
we also found ourselves at some point, and which prompted us to organize these issues. A 
discussion of DDH is only possible if the debaters are based on a consensus understanding 
of the same concepts. Therefore, in the manuscript, we have included a number of 
definitions (from professional literature) so that every attentive reader has no doubts about 
what we are writing about and what we are referring to, and in order to precisely and 
unambiguously describe the issue. 
We would like to emphasize the differences between dysplasia and deformation (Latin 
deformatio) in the medical sense, which perhaps in the original text of the manuscript is not 
emphasized enough to be properly perceived by the reviewer. In order to explain our view 
more clearly, we must return to the explanation of the terms we use. The interchangeable 
use of similar meaning words such as distortion and deformity, distortion and 
malformation, deformation (or deformity) and dysplasia is used in everyday language. On 
the level of medical considerations, however, it is not acceptable.  And this is not just our 
opinion. Leading publication in the field of orthopedics J. P. Dormans "Pediatric Orthopedics: 
Core Knowledge in Orthopedics" in Chapter I by Steven L. Frick entitled "Concepts of proper 
human growth and development in pediatric orthopedics" explains the differences in the 
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concepts of dysplasia, deformation and distortion, on which we have based our 
considerations. 
The term dysplasia refers to tissue whose structure is defective or poorly constructed; 
disturbed development causes disturbed anatomy. It is one of the four defect 
pathomechanisms. Following [Tachdjian's Pediatric Orthopedics [Chapter 01]], dysplasia is 
similarly defined, ie: 
„Dysplasias are structural defects caused be abnormal tissue differentiation as cell organize into 
tissues”. 
The term deformity (or deformation) refers to a properly developed anatomical structure 
that has been deformed by mechanical factors. This is another of the four defect 
pathomechanisms. 
In the publication [Tachdjian's Pediatric Orthopedics [Chapter 01]] one can find another 
confirmation of the above definition: 
„Deformations are defects in the form, shape, or site of body parts caused by mechanical stress. 
The mechanical stress, which may be intrinsic or extrinsic, alters or distorts tissue. Because the 
fetus grows considerably faster than the infant, fetus are more vulnerable to deformations”. 
Distortion is a pathological condition in which the shape of a part of the body has 
remodeled beyond the normal range. Distortion is therefore an overarching term that 
described both deformation and malformation, as well as dysplasia. 
In connection with the above, deformation (deformity) in medical terms can by no means be 
dysplasia, let alone malformation (Latin malformatio), but all of the above can lead to 
distortions of parts of the human body. The distinguishing of these terms is crucial for the 
correct diagnosis and subsequent therapeutic management, which is fraught with 
consequences. The effects of conservative or surgical treatment will be different in the case 
of Developmental Deformity of the Hip Joint and in the case of Developmental Dysplasia of 
the hip joint. 
The reviewer used the term deformity to refer to malformation as synonyms. In our study, 
we pay attention to the fact that such processes are commonly erroneous interchangeably 
used. Suffice it to mention that by the term malformation some scientists describe various 
issues, e.g. 
-> malformation as a pathomechanism of developmental defects, which is acting in the 
embryonic period 
-> malformation as a synonym of distortion and often for this reason incorrectly called 
deformity (deformation), which is another pathomechanism of developmental defects 
completely different from malformation 
-> malformation as a developmental defect 
causing confusion in the interpretation of medical scientific reports. In our publication, we 
understand malformation as one of the four pathomechanisms of defects alongside 
dysplasia, deformity and disruption as defined contained in [Tachdjian's Pediatric 
Orthopedics [Chapter 01]]: 
„Malformation are structural defects that result from interruption of normal organogenesis 
during the second month of gestation”. 
“ It is important to differentiate deformations form malformations. (…) Malformations 
cannot be corrected directly,, whereas deformations can often be revised relatively easily either 
by elimination the deforming force or by counteracting the force with stretching, casting, or 
bracing”. 
This particular pathomechanism only works in the embryonic period and underlies the 
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teratogenic hip dislocation. 
The aim of the publication was to draw attention to the extent to which DDH is based on the 
pathomechanism of dysplasia, and to what extent on the pathomechanism of deformation, 
and to draw attention to the need to refine diagnostic schemes to distinguish these disease 
entities, which is currently not fully implemented despite the technical possibilities. 
Currently, as we claim, not every officially diagnosed developmental dysplasia is in fact a 
disease whose pathomechanism is pure dysplasia. Some of them are most likely a 
developmental deformity. The evidence showing the presence of diagnostically mute and 
clinically mute cases supports the above thesis. For this reason, we have proposed an 
orderly division of DDH along with the nomenclature. We are not claiming that the division 
presented in our manuscript is perfect. It certainly needs discussion and perhaps 
modification, but we hope it will contribute to serious consideration on this topic as it seems 
necessary. 
We hope that the description of the topics raised by the reviewer will help readers 
understand the essence of the matter and the need to organize the issue of DDH, as well as 
start discussing the extension of diagnostic schemes.  
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